QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
NASDAQ:KA

Kineta - KA Stock Forecast, Price & News

$3.01
-0.20 (-6.23%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.94
$3.41
50-Day Range
$3.01
$8.33
52-Week Range
$2.94
$17.43
Volume
67,825 shs
Average Volume
22,597 shs
Market Capitalization
$4.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

KA stock logo

About Kineta (NASDAQ:KA) Stock

Kineta, Inc. is a clinical-stage biotechnology company, which develops immunotherapies for cancer patients. Its immuno-oncology focused platform aims at developing fully human antibodies to address the major mechanisms of cancer immune resistance. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.

Receive KA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter.

KA Stock News Headlines

How This Trader Banked A 97% Win Rate
Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. pixel
Kineta, Inc. (KA)
See More Headlines
Receive KA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter.

KA Company Calendar

Today
3/20/2023
Next Earnings (Estimated)
3/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-39,500,000.00
Net Margins
-660.61%
Pretax Margin
-660.61%

Debt

Sales & Book Value

Annual Sales
$8.04 million
Book Value
$15.95 per share

Miscellaneous

Free Float
1,360,000
Market Cap
$4.67 million
Optionable
Not Optionable
Beta
0.49

Key Executives

  • Shawn P. Iadonato
    Chief Executive Officer & Director
  • Craig W. Philips
    President
  • Keith Baker
    Chief Financial Officer
  • Thierry Guillaudeux
    Chief Scientific Officer
  • Jacques Bouchy
    EVP-Investor Relations & Business Development













KA Stock - Frequently Asked Questions

How have KA shares performed in 2023?

Kineta's stock was trading at $6.35 at the beginning of 2023. Since then, KA stock has decreased by 52.6% and is now trading at $3.01.
View the best growth stocks for 2023 here
.

When is Kineta's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023.
View our KA earnings forecast
.

What is Kineta's stock symbol?

Kineta trades on the NASDAQ under the ticker symbol "KA."

Who are Kineta's major shareholders?

Kineta's stock is owned by many different institutional and retail investors. Top institutional investors include Artal Group S.A. (2.00%) and Renaissance Technologies LLC (1.13%).

How do I buy shares of Kineta?

Shares of KA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Kineta's stock price today?

One share of KA stock can currently be purchased for approximately $3.01.

How much money does Kineta make?

Kineta (NASDAQ:KA) has a market capitalization of $4.67 million and generates $8.04 million in revenue each year. The company earns $-39,500,000.00 in net income (profit) each year or ($20.9937) on an earnings per share basis.

How can I contact Kineta?

Kineta's mailing address is 40 GUEST STREET SUITE 4410, BOSTON MA, 02135. The official website for the company is www.kinetabio.com. The company can be reached via phone at (206) 378-0400 or via email at lroth@burnsmc.com.

This page (NASDAQ:KA) was last updated on 3/20/2023 by MarketBeat.com Staff